Amneal Pharmaceuticals Inc.

Apr 10, 2020

Global Active Pharmaceutical Ingredients Market 2020-2024 | Evolving Opportunities with Amneal Pharmaceuticals Inc. and Cadila Healthcare Ltd. | Technavio

May 13, 2019

AMNEAL INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Amneal Pharmaceuticals, Inc. To Contact The Firm

Mar 06, 2019

Amneal Pharmaceuticals to Present at the Barclays Global Healthcare Conference

Jan 24, 2019

Amneal to Report Fourth Quarter and Full Year 2018 Results on February 28, 2019

Dec 19, 2018

Amneal Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference

Nov 12, 2018

Lannett Enters Into Agreement With Amneal Pharmaceuticals For Levothyroxine

Sep 24, 2018

Amneal to Present at the Cantor Fitzgerald Global Healthcare Conference

Sep 21, 2018

Amneal to Report Third Quarter 2018 Results on November 7, 2018

Aug 31, 2018

Amneal to Present at Upcoming Investor Conferences

Jun 29, 2018

Amneal to Report Second Quarter 2018 Results on August 9, 2018

Jun 06, 2018

Amneal to Present at the Goldman Sachs 39th Annual Global Healthcare Conference

May 23, 2018

mAbxience and Amneal Enter Into an Agreement for Bevacizumab Biosimilar in the United States

Dec 18, 2017

Robert Stewart to Join Amneal Pharmaceuticals as President

Oct 17, 2017

Amneal And Impax To Combine